New cases tested for RR-/MDR-TB in Sur
Sur: New cases tested for RR-/MDR-TB was 97.0% in 2024. β Volatile
Latest (2024)
97.0%
Change on year
up 1.0%
Rank
1st
of 2 regions
All-time high
100.0%
in 2015
All-time low
0.0%
in 2011
Years of data
18
2005β2024
New cases tested for RR-/MDR-TB in Sur, 2005β2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, new cases tested for rr-/mdr-tb in Sur stood at 97.0%.
Compared with earlier readings it is up 1.0% on the previous year and up 10.2% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Sur peaked at 100.0% in 2015 and was at its lowest, 0.0%, in 2011.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.2% | 0.7% | 52.0% | 3 |
| 2010s | 62.2% | 0.0% | 100.0% | 10 |
| 2020s | 97.2% | 96.0% | 99.0% | 5 |
Countries ranked near Sur
- 1 Brunei Darussalam 100.0% compare
- 1 Fiji 100.0% compare
- 1 Seychelles 100.0% compare
- 1 Chile 100.0% compare
- 1 Montenegro 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Slovenia 100.0% compare
- 1 Ecuador 100.0% compare
- 1 Barbados 100.0% compare
- 1 Eswatini 100.0% compare
- 1 Qatar 100.0% compare
- 1 Zimbabwe 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Lao People's Democratic Republic 100.0% compare
- 1 Armenia 100.0% compare
- 1 Iraq 100.0% compare
- 1 Costa Rica 100.0% compare
- 1 Albania 100.0% compare
- 1 Kuwait 100.0% compare
- 1 Oman 100.0% compare
- 1 Iceland 100.0% compare
- 1 Palau 100.0% compare
- 1 Bhutan 100.0% compare
- 1 New Zealand 100.0% compare
- 1 Afghanistan 100.0% compare
- 1 Benin 100.0% compare
- 1 Republic of Moldova 100.0% compare
- 1 Marshall Islands 100.0% compare
- 1 Belarus 100.0% compare
- 1 Samoa 100.0% compare
- 1 Lithuania 100.0% compare
- 1 Turkmenistan 100.0% compare
- 1 Jamaica 100.0% compare
- 1 Korea 100.0% compare
- 1 Morocco 100.0% compare
- 1 Belize 100.0% compare
- 1 Israel 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Eritrea 100.0% compare
- 1 Tonga 100.0% compare
- 1 Grenada 100.0% compare
- 1 Kazakhstan 100.0% compare
- 1 Ghana 100.0% compare
- 1 Togo 100.0% compare
- 1 Saint Vincent and the Grenadines 100.0% compare
- 1 Comoros 100.0% compare
- 1 Naoero 100.0% compare
- 1 Djibouti 100.0% compare
- 1 Saint Kitts and Nevis 100.0% compare
- 2 Cook Islands 0.0% compare
More health data for Sur
- Pertussis - number of reported cases 8 (2025)
- Measles - number of reported cases 0 (2025)
- Diphtheria - number of reported cases 0 (2025)
- Total tetanus - number of reported cases 0 (2025)
- Neonatal tetanus - number of reported cases 0 (2025)
- Overweight among adults, BMI β₯ 25 kg/m2 (age-standardized estimate) 59.9% (2024)
- Infant mortality rate (probability of dying between birth and age 1) 14.76 (2024)
- Under-five mortality rate 15.79 (2024)
- Obesity among children and adolescents, BMI-for-age > +2 standard 20.4% (2024)
- Thinness among children and adolescents, BMI-for-age < -2 standard 4.3% (2024)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Sur?
- New cases tested for rr-/mdr-tb in Sur was 97.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Sur?
- The highest recorded value was 100.0% in 2015.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Sur?
- The lowest recorded value was 0.0% in 2011.
- How does Sur rank for new cases tested for rr-/mdr-tb?
- Sur ranks 1st out of 2 regions with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Sur?
- Over the last ten years it is up 10.2%. The long-run trend across the full record is volatile.
- Where does this Sur data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).